JPMorgan Chase & Co’s Fennec Pharmaceuticals FENC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$91.9K Sell
11,077
-644
-5% -$5.35K ﹤0.01% 4829
2025
Q1
$71.4K Buy
11,721
+952
+9% +$5.8K ﹤0.01% 4895
2024
Q4
$68.1K Buy
10,769
+264
+3% +$1.67K ﹤0.01% 4909
2024
Q3
$52.5K Buy
10,505
+191
+2% +$955 ﹤0.01% 4965
2024
Q2
$63K Buy
10,314
+491
+5% +$3K ﹤0.01% 4819
2024
Q1
$109K Sell
9,823
-3,276
-25% -$36.4K ﹤0.01% 4698
2023
Q4
$147K Buy
13,099
+1,266
+11% +$14.2K ﹤0.01% 4600
2023
Q3
$88.9K Sell
11,833
-2,699
-19% -$20.3K ﹤0.01% 4680
2023
Q2
$128K Buy
14,532
+14,462
+20,660% +$128K ﹤0.01% 4524
2023
Q1
$1K Hold
70
﹤0.01% 5646
2022
Q4
$1K Hold
70
﹤0.01% 5448
2022
Q3
$1K Sell
70
-7,665
-99% -$110K ﹤0.01% 5401
2022
Q2
$69K Sell
7,735
-8,631
-53% -$77K ﹤0.01% 4762
2022
Q1
$91K Buy
16,366
+16,296
+23,280% +$90.6K ﹤0.01% 4782
2021
Q4
$0 Buy
+70
New ﹤0.01% 5762
2021
Q3
Sell
-20,021
Closed -$146K 5579
2021
Q2
$146K Sell
20,021
-2,893
-13% -$21.1K ﹤0.01% 4626
2021
Q1
$142K Buy
22,914
+13,244
+137% +$82.1K ﹤0.01% 4568
2020
Q4
$72K Buy
9,670
+1,699
+21% +$12.7K ﹤0.01% 4368
2020
Q3
$48K Buy
7,971
+706
+10% +$4.25K ﹤0.01% 4285
2020
Q2
$61K Buy
+7,265
New +$61K ﹤0.01% 4144
2019
Q4
Sell
-110
Closed -$1K 4750
2019
Q3
$1K Buy
+110
New +$1K ﹤0.01% 4713
2019
Q2
Sell
-2,831
Closed -$14K 4847
2019
Q1
$14K Sell
2,831
-802
-22% -$3.97K ﹤0.01% 4569
2018
Q4
$23K Buy
3,633
+946
+35% +$5.99K ﹤0.01% 4471
2018
Q3
$22K Sell
2,687
-35,449
-93% -$290K ﹤0.01% 4557
2018
Q2
$398K Buy
+38,136
New +$398K ﹤0.01% 3549